Purine nucleoside phosphorylase [PNP] deficiency digital illustration

Purine nucleoside phosphorylase [PNP] deficiency Save


ICD-10 code: D81.5

Disease category: D81: Combined immunodeficiencies

Purine Nucleoside Phosphorylase [PNP] Deficiency: An Overview

Purine nucleoside phosphorylase (PNP) deficiency is a rare inherited disorder that affects the body's ability to break down purine nucleosides, leading to a buildup of toxic substances in the body. This condition is caused by mutations in the PNP gene, which is responsible for producing the PNP enzyme.

PNP deficiency is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. The severity of symptoms can vary widely among affected individuals, ranging from mild to severe.

Common signs and symptoms of PNP deficiency include immune system dysfunction, neurological abnormalities, and impaired growth. Individuals with this condition often experience recurrent infections, such as respiratory or urinary tract infections, due to a weakened immune system.

In addition to immune system dysfunction, PNP deficiency can also affect the central nervous system, leading to neurological problems. These may include developmental delays, intellectual disability, muscle weakness, and seizures. Some individuals may also have skeletal abnormalities, such as short stature.

Diagnosing PNP deficiency typically involves a combination of clinical evaluations, genetic testing, and enzyme activity measurements. Early diagnosis is important to guide appropriate management and treatment strategies.

  1. Genetic testing: DNA analysis can identify mutations in the PNP gene, confirming the diagnosis.
  2. Clinical evaluation: A thorough physical examination and medical history review can help identify characteristic signs and symptoms of the condition.
  3. Enzyme activity measurements: Blood or tissue samples can be analyzed to measure the activity of the PNP enzyme, which is typically reduced or absent in individuals with PNP deficiency.

Management of PNP deficiency mainly focuses on addressing the specific symptoms and complications associated with the condition. This may include supportive care, such as treating infections promptly and providing physical and occupational therapy to address developmental delays and muscle weakness.

In conclusion, PNP deficiency is a rare genetic disorder that affects the body's ability to break down purine nucleosides. It can lead to immune system dysfunction, neurological abnormalities, and impaired growth. Early diagnosis and appropriate management are crucial for improving the quality of life for individuals living with this condition.

Treatment of Purine nucleoside phosphorylase [PNP] deficiency:

Treatment Options for Purine Nucleoside Phosphorylase [PNP] Deficiency

Purine nucleoside phosphorylase (PNP) deficiency is a rare inherited disorder that affects the immune system and the production of T cells, which are vital for fighting infections. This condition can lead to a range of symptoms, including recurrent infections, neurological abnormalities, and autoimmune disorders...

To see full information about treatment please Sign up or Log in